PR

OG

RA

M AT A

GLA

NC

E

Wednesday, 3rd April, 2013

Thursday, 4th April, 2013

(Hall A) (Hall B)

09:00-09:15 Introduction 09:00-11:00 Workshop I: Nursing 09:15-09:45 Memorial Lecture:

Prof. Lotfy Abo Elnasr - Prof. El-Sebaie 09:45-10:45 Session I: Updates in The Diagnosis of Breast Cancer

10:45-11:00 Coffee Break 11:00-11:30 Coffee Break

11:00-12:00 Session II: Controversies in The Surgical Management of Breast Cancer

11:30-13:30 Workshop II: Molecular Diagnostics in Breast Cancer 12:00-12:40 Debate: Chemoprevention of Breast Cancer12:40-14:00 Session III: Controversies in Adjuvant Breast

Cancer Therapy

14:00-15:30 Lunch Break 13:30-15:00 Lunch Break

15:30-17:00 NOVARTIS SYMPOSIUM GIST AND NET 15:00-17:30 Workshop II: Molecular Diagnostics in Colorectal Cancer17:00-18:30 (Hall C) Session IV: Hepatobiliary Cancer: Diagnostics and Interventional Radiology Standards of 2013

18:30-20:00 (Hall A) Opening Ceremony20:00-22:00 Dinner Symposium (GSK)

(Hall A) (Hall B)

09:00-10:30 Session V: Approaches in Management of Early 09:00-10:30 Workshop III: Breast Cancer and PregnancyStage Colorectal Carcinoma

10:30-11:30 Presidential Lecture CML

11:30-12:00 Coffee Break 11:30-12:00 Coffee Break

PR

OG

RA

M AT A

GLA

NC

E12:00-12:30 Memorial Lecture: Prof. Hassan Awad 12:00-14:00 Janssen Cilag Workshop IV: Pain 12:30-14:15 Session VI: Different Approaches for

Locallyadvanced and Metastatic CRC14:15-15:00 Session VII: Neoadjuvant Treatment for Rectal

Carcinoma: 2013

15:00-16:30 ROCHE SYMPOSIUM - Lunch Break

16:30-17:50 Session VIII: Advanced Breast Cancer 16:30-17:30 Session XIII: Novel Approaches in Current Current Updates Management

17:50-18:30 LEO PHARMA: Special Lecture VTEin Breast Cancer 17:30-18:00 PFIZER: Special Lecture18:30-19:30 NOVARTIS SYMPOSIUM Breast Cancer

20:30 Gala Dinner (Only by Invitation)

(Hall A) (Hall B)

09:00-10:10 Session IX: Upper GI Tumors: Controversies in 10:00-12:00 Workshop V: the Current Management Elsevier: The Art of Scientific Publication

10:00-10:30 Coffee Break

10:30-11:45 Session X: Updates in Diagnosis & Interventional Management of GIT Cancers

12:00-13:00 Friday prayer

13:00-14:00 Lunch

14:00-15:00 Session XI: Pancreatic Cancer: Avenues to 14:00-15:30 Session IVX: Poster Discussionthe New Standards

15:00-16:50 Session XII: Advances in the Management of Hepatocellular Carcinoma

17:00-17:30 Memorial Lecture: Prof. Nazligad El Mawla 15:30-17:30 Session VX: Advances in Radiodiagnosis

17:30-18:30 Closing Remarks and Recommendation

Friday, 5th April, 2013

PROGRAM

Wednesday, 3rd April, 2013

08:30-09:00 Registration

Hall (A)

09:00-09:15 Introduction

09:15-09:45 Memorial Lecture: Prof. Lotfy Abo Elnasr - Prof. El-sebaie Chairpersons: Amal Samy - Dimitris Bafaloukos - Kamal El Ghamrawy - Sherif Omar - Zekri Khaled

09:15-09:45 Breast Cancer in Egypt: Past, Present and FutureHussein Khaled (Egypt)

09:45-10:45 Session I: Updates in the Diagnosis of Breast CancerChairpersons: Dorria Salem - Magda Mourad - Mohamed Shaalan - Moharam El Badawi -

Sami El Khatib - Walid Omar

09:45-10:05 Role of Contrast Mammography in Screening and DiagnosisMaha Helal (Egypt)

10:05-10:25 Controversial Role of PET CT in Breast CancerHussein Abdel Dayem (USA)

10:25-10:45 Molecular characterizations of Breast cancer Saad Eissa (Egypt)

10:45-11:00 Coffee Break

11:00-12:00 Session II: Controversies in the Surgical Management of Breast Cancer Chairpersons: Ahmed El-Saeed - Faisal Amer - Hassan Meebed - Moustafa Abo El Nasr -

Osama Soliman

11:00-11:20 "HER2gene status": new evaluation criteria Millo Fratini (Switzerland)

11:20-11:40 Challenges in breast Conservative Surgery: The Surgeon's PerspectiveAhmed Farahat (Egypt)

11:40-12:00 Updates in The Management of Axillary Lymph nodes in Breast Cancer.Omar Zakria (Egypt)

12:00-12:40 Debate: Chemoprevention of Breast CancerChairpersons: Gamal El-Houseny - Nasr Al-Lahloubi - Tanja Cufer - Yasser Abdel Kader

12:00-12:40 Debates in Breast Cancer ChemopreventionYes: Rabab Gaafar(Egypt)No: Alaa Kandil(Egypt)

PROGRAM

Wednesday, 3rd April, 2013 Hall (A)

12:40-14:00 Session III: Controversies in Adjuvant Breast Cancer Therapy

Chairpersons: Hamdy Abdel Azim - Heba El-Zawahry - Magda El Mongy - Manal Moawad - Mohsen Barsoum

12:40-13:00 Updates on chemotherapy and Targeted therapy in Adjuvant BreastTanja Cufer (Slovenia)

13:00-13:20 Should partial breast radiotherapy be a standard of care?John Yarnold (UK)

13:20-13:40 Hypofractionation for early breast cancerJohn Yarnold (UK)

13:40-14:00 Controversial Issues in adjuvant Hormonal therapy of Breast CancerSanna El Sukhun (Jordan)

14:00-15:30 Lunch Break

15:30-17:00 NOVARTIS Symposium GIST and NET

Chairpersons: Eman Fouad - Hamdy Abdel Azim - Mostafa Manieh

15:30-15:50 NET PathologyNadia Mokhtar (Egypt)

15:50-16:10 NET TreatmentYasser Abdel Kader (Egypt)

16:10-16:30 GISTAxel Le Cene. Gustave Roussy (France)

16:30-16:50 Metastatic GISTMostafa El-Serafi (Egypt)

16:50-17:00 Discussion

18:30-20:00 Opening Ceremony

20:00-21:00 Symposium (GSK): Managing Her2 Positive Metastatic Breast Cancer, Doing a Better Job?

Chairpersons: Abbas Omar- Rabab Gaafar - Yaser Abdel Kader

20:00-20:30 Lapatinib as first line treatment in Her2 positive MBCHeba El-zawahry (Egypt)

20:30-21:00 CNS metastasic in Her2 positve breast cancer, the systemic side of the story.Hamdy A Azim (Egypt)

21:00-22:00 GSK Dinner

PROGRAM

Wednesday, 3rd April, 2013

Hall (B)

09:00-11:00 Workshop I: Nursing Workshop1- Rehabilitation of breast cancer patients2- Maintaining quality of life for breast cancer patients3- Psychological care support for breast cancer patients4- Rehabilitation of colorectal cancer patients5- Psychological support for colorectal Cancer patients

11:00-11:30 Coffee Break

11:30-17:30 Workshop II: Molecular Diagnostics for Clinical Oncology

Organized by: National Cancer Institute - Egypt and Mediterranean Multidisciplinary Oncology Forum (MMOF)

Session I: Breast Cancer Chairpersons: Dimitris Bafaloukos, Keith Miller, Nadia Mokhtar

11:30-12:00 Implications of breast cancer stem cells: a base for a molecular classificationNadia Mokhtar (Egypt)

12:00-12:30 Clinical implementation and utility of molecularly defined Breast Cancer subsetsHelena Linardou (Greece)

12:30-13:00 25 years of external quality assessment (EQA): Where are the pitfalls?Keith Miller (UK)

13:00-13:30 Panel Discussion: Critical issues in implementation of Diagnostic Accuracy: Pathology to molecular medicine

13:30-15:00 Lunch Break

Session II: Colorectal CancerChairpersons: Magda Mourad, Milo Frattini, Samuel Murray

15:00-15:30 K-ras mutations in metastatic colorectal cancerMilo Frattini (Switzerland)

15:30-16:00 Her-2 in breast and colorectal cancers: the same marker but different evaluation criteria and different clinical implications.Milo Frattini (Switzerland)

16:00-16:30 Examining the correlation between inherited and somatic carcinogenesis in Colorectal cancer: How to manage integration.Samuel Murray (UK)

16:30-17:00 Challenges of providing a high quality diagnostic service to the community and quality control issues.Keith Miller (UK)

17:00-17:30 Panel Discussion: Critical issues in implementation of diagnostic accuracy: Pathology to molecular medicine.

PROGRAM

Wednesday, 3rd April, 2013

Hall (C)

17:00-18:30 Session IV: Hepatobiliary Cancer: Diagnostics and Interventional Radiology Standards of 2013

Chairpersons: Ahmed El-Dory - Ashraf Omar - Ekram Hamed - Inas Abdel Halim - Osama El Malt

17:00-17:30 Hepatocellular carcinoma: Can MR imaging replace tissue diagnosis?Sherif Nour (USA)

17:30-18:00 Updates on liver embolization DEB TACE and Y-90 Radio-embolizationKevin Kim (USA)

18:00-18:30 Interventional MRI: Expanding the options for patients with GIT malignanciesSherif Nour (USA)

PROGRAM

Thursday, 4th April, 2013

(Hall A)

09:00-10:30 Session V: Approaches in Management of Early Stage Colorectal Carcinoma

Chairpersons: A. Aziz Belal - Ahmed Seleem - Inas El-Attar - Mounier Abo El-Ela - Sabry Shaarawy

09:00-09:20 NCI hospital based cancer registry 2002-2010Nelly Ali Eldin (Egypt)

09:20-09:40 Laparoscopic colorectal surgery, how far it can be safe?Waheed Yosry (Egypt)

09:40-10:10 Total peritoneal reconstruction after abdomeno-peroneal resectionOmaya Abdel Hamid (Egypt)

10:10-10:30 Update on adjuvant therapy of colon cancer; what works, what does not and what is next? Nasr Al-Lahloubi (Egypt)

10:20-10-30 Discussion

10:30-11:30 Presidential Lecture CML

Chairpersons: Alaa El-Haddad - Azza Kamal - Hamdy El Zawam - Hossam Kamel - Mervat Mattar - Mohamed Abdel Mooti

10:30-11:00 Choice of therapy in today's newly diagnosed CML patientsHossam Kamel (Egypt)

11:00-11:30 Like Sailing Down the Nile…The History of Therapy for Chronic Myeloid LeukaemiaMicheal Copeman (Australia)

11:30-12:00 Coffee Break

12:00-12:30 Memorial Lecture: Prof. Hassan Awad

Chairpersons: Ehsan El Ghoneimy - Hany Akosh - Laila Moussa - Mervat El Naggar - Samy El Badawy - Somia Ezzat

12:00-12:30 The role of pre-operative radiation in rectal carcinoma- an overviewMay Abdel Wahab (USA)

PROGRAM

Thursday, 4th April, 2013

(Hall A)

12:30-14:15 Session VI: Different Approaches for Locally Advanced and Metastatic CRC

Chairpersons: Abbas Omar - Hany El Naggar - Magda Mostafa - Mohamed Abbas - Naeir El-Ghamry

12:30-12:50 Treatment of local recurrence after rectal resection including sacrectomyMedhat Khafaga (Egypt)

12:50-13:10 Interventional treatment of refractory ascitisLouis G Martin (USA)

13:10-13:30 Systemic Chemotherapy for metastatic CRC: a molecular approachMostafa El Serafi (Egypt)

13:30-13:50 Colonic stenting for advanced CRC Amr El Saadani (KSA)

13:50-14:15 Discussion

14:15-15:00 Session VII: Neoadjuvant Treatment for Rectal Carcinoma: 2013

Chairpersons: Hanna Kohail - Magdi Saber - Mostafa El Serafi - Omar Zaky - Saeed El Newiem - Tarek Hashem

14:15-15:00 Current Status of ManagementMohsen Mokhtar (Egypt)

Interviewer: Ola Khorshid (Egypt)

15:00-16:30: ROCHE Symposium and Lunch BreakOrchestrating The Treatment of Breast Cancer

Chairpersons: Nasr Al Lahlouby - Nivene Gado - Saeed El Noeam

15:00-15:30 Management of HER2 positive eBC; Recent UpdatesAlaa Kandil (Egypt)

15:30-16:00 First Line Treatment of HER2 positive mBC; What is best for the patients?Ibtessam Saad Eldeen (Egypt)

16:00-16:30 Chemotherapy options in MBC; Thinking SmartOla Khorshid (Egypt)

PROGRAM

Thursday, 4th April, 2013

(Hall A)

16:30-17:50 Session VIII: Advanced Breast Cancer Current Updates

Chairpersons: Abbas Omar - Eman Fouad - Hazim El Akkad - Samuel Murray - Shawki El HaddadTanja Cufer

16:30-16:50 Optimal systemic treatment for locally advanced breast cancerAhmed Saad El Din (KSA)

16:50-17:10 Triple negative breast cancer: biology and new therapeutic approachesAhmad Awada (Belgium)

17:10-17:30 Advances in the treatment of HER 2 positive metastatic breast canerHelena Linardou (Greece)

17:30-17:50 Brain metastasis in breast cancerNuhad Ibrahim (USA)

17:50-18:30 LEO Pharma Special Lecture VTE in Breast Cancer

Chairpersons: Magdy El Shahawy - Nasr Al-Lahlouby - Salah El Mesedy - Wafaa El-Metnawey -Wafaa Tahaa

17:50-18:30 Update on cancer related thrombosisAnthony Maraveyas (UK)

18:30-19:30 NOVARTIS Symposium: Breast Cancer

Chairpersons: Heba El-Zawahry - Ismail Siala - Yousry Gouda

18:30-19:30 How does resistance to endocrine therapy affect the Breast Cancer outcome?Tanja Cufer (Slovenia)

Role of m-TOR in Metastatic Breast cancerAre m-TOR Inhibitors effective in bone and Visceral MetastasisRabab Gaafar (Egypt)

20:30 Gala Dinner (Only by Invitation)

PROGRAM

Thursday, 4th April, 2013

(Hall B)

09:00-10:30 Workshop III: Breast Cancer and Pregnancy

Chairpersons: Helena Linardou - Hesham El Ghazaly - Hoda Abdel Baki - Lobna Ezz El Arab - Rabab Gaafar

09:00-09:20 Consideration in the local management of breast cancer during pregnancyOmar Z. Youssef (Egypt)

09:20-09:45 Systemic treatment of breast cancer during pregnancySanaa El Sukhun (Jordan)

09:45-10:10 Fertility considerations and subsequent pregnancy in young breast cancer patientsHatem Abdel Azim (Belgium)

10:10-10:30 Case discussions - 2 casesSanaa El Sukhun (Jordan)

12:00-14:00 JANSSEN CILAG Workshop IV: Pain Moderators: Ahmed Helmy - Khaled Abdel Hameed

Opioids in cancer patients (basic concepts and clinical uses) Interactive cases presentation.

15:00-16:30 Lunch

16:30-17:30 Session XIII: Novel Approaches in Current ManagementChairpersons: Ahmed El Zawawy - Hassan Abdalla - Nabil El Bolkeiny - Nayera Anwar -

Sameh Shamaa - Samia Akel

16:30-16:40 Diagnostic approach of Micro RNA in diagnosis of hepatocellular carcinomaAbdel Hady Ali (Egypt)

16:40-16:50 Dose escalation in rectal cancer- dosimetric analysis"Ehab Khalil (KSA)

16:50-17:00 Role of pulmonary metastatectomy in breast and GIT tumorsAbdel Rahman M. Abdel Rahman (Egypt)

17:00-17:10 Tumor Marker in Breast CancerAmal Fawzy (Egypt)

17:10-17:20 Role of immunostaining and image-guided FNA cytology in the diagnosis of HCCMohamed Zaakouk (Egypt)

17:20-17:30 Discussion

17:30-18:00 PFIZER: Special Lecture Sustained Benefit of aromatase Inhibitors in adjuvant Therapy for Postmenopausal Breast Cancer Patients - Heba El Zawahry (Egypt)

PROGRAM

Friday, 5th April, 2013

(Hall A)

09:00-10:10 Session IX: Upper GI Tumors: Controversies in the Current Management

Chairpersons: Ashraf Barakat - Assem Roustom - Mohamed Saad Zaghloul - Mostafa Maniea -Samir Shehata

09:00-09:20 Role of endosonography in the management of upper GI tumorsRathod (India)

09:20-09:40 Advances in surgical management of gastric carcinoma Mohamed Gamil (Egypt)

09:40-9:55 Optimal management for locally advanced gastric and esophageal tumors:Radiotherapy perspectivesTarek Shouman (Egypt)

9:55-10:10 Role of targeted therapy in Stomach CancerOsman Mansour (Egypt)

10:10-10.30 Coffee Break

(10:30-11:45) Session X: Updates in Diagnosis & Interventional Management of GIT Cancers

Chairpersons: Amr Abdel Aziz - Assma Abo Rabia - Atef Yousef - Fouad AbouTaleb - Mohamed El-Safa

10:30-10:50 Role of PET in GIT tumorsHussein Abdel Dayem (USA)

10:50-11:10 Portal vein embolization before hepatic resectionWael E. Saad (USA)

11:10-11:30 Pancreatic cancer: Overview of imaging, diagnosis and percutaneous interventionSherif Nour (USA)

11:30-11:45 Discussion

12:00-13:00 Friday prayer

13:00-14:00 Lunch

PROGRAM

Friday, 5th April, 2013

(Hall A)

(14:00-15:00) Session XI: Pancreatic Cancer: Avenues to the New Standards

Chairpersons: Ahmed Badeeb - Ahmed Morsy - Nadia El Deeb - Sherif Abd El Aziz - Sherif MamounSalah Abdel Moneim

14:00-14:20 Advances in Pancreatic SurgeryHussein Soliman (Egypt)

14:20-14:40 Current status of Adjuvant Systemic Treatment in Pancreatic CarcinomaAhmed Abdel Maboud (Egypt)

14:40-15:00 Updates in the Management of Metastatic Pancreatic CarcinomaEmad Hamada (Egypt)

(15:00-16:50) Session XII: Advances in the Management of Hepatocellular Carcinoma

Chairpersons: Ibtesam Saad El Din - Mohamed Lotayef - Neveen El Hefnawy - Osama El Malt - Thoria Abdel Hamid - Yosry Rustum

15:00-15:20 Novel markers in HCCIman Attia (Egypt)

15:20-15:40 How to avoid complications in major hepatectomies?Mohamed El Kalawy (Egypt)

15:40-16:00 Anaethetic techniques and hepatobiliary cancer recurrenceKhaled Abdel Hamid (Egypt)

16:00-16:20 Novel treatment in advanced hepatocellular carcinomaMagdy Saber (Egypt)

16:20-16:40 Sterotactic body radiosurgery in the management of Hepatocellular carcinomaMay Abdel Wahab (USA)

16:40-16:50 Discussion

(17:00-17:30) Memorial Lecture: Professor Nazli Gad El Mawla

Chairpersons: Ahmed El Khodary - Heba El-Zawahry - Hussien Khaled - Magdi Saber - Nasr Al-Lahlouby - Rabab Gaafar

17:00-17:30 The long term benefits of neoadjuvant in breast cancer with a special emphasis in TNBC.Ahmad Awada (Belgium)

17:30-18:30 Closing Remarks and Recommendation

PROGRAM

Friday, 5th April, 2013

(Hall B)

(10:00-12:00) Workshop V: Elsevier: The Art of Scientific Publication

Chairpersons: Ahmed Abdel Maboud - Heba Shaker - Hanan Ramadan

10:00-10:45 Authoring a world class paper Anne Marie Pordon (Jordan)10:45-11:00 Discussion

11:00-11:45 The impact Factor and other bibliometricsAnne Marie Pordon (Jordan)

11:45-12:00 Discussion

12:00-13:00 Friday prayer

13:00-14:00 Lunch

(14:00-15:30) Session IVX: Poster Discussion

Chairpersons: Amani Helal - Hatem Abou Elkassem - Ibrahim Abdel Salam - Iman Gouda - Khaled Abou El Einein - Manar Mounir

P1. A prospective pharmacokinetic study of docetaxel in breast cancer patients in relation to CYP3A4 Activity

P2. A study of serum levels of vitamin D, ionized calcium and phosphorus in Egyptian breast cancer females: a Case Control Study

P3. Pancreatic Carcinoma Role of Multislice tripahsic CT in assessment of tumor resectability, prospective study

P4. Dose escalation in rectal cancer; for whom, why and how?P5. Molecular Characterization of Local Streptomyces Isolates and Determination of their

Antimicrobial and Anticancer ActivitiesP6. Fertility considerations and subsequent pregnancy in young breast cancer patientsP7. Natural history of untreated hepatocellular carcinoma: A single institute

retrospective studyP8. Breast cancer laterality among Egyptian patients and its correlation with treatments

and survivalP9. Role of hypermethylation of RASSF1A & PROTOCADHERIN-10 promoter regions as

molecular diagnostic and prognostic markers in Egyptian breast cancer patients P10. Peripheral blood mammaglobin gene expression for diagnosis and prediction of

metastasis in breast cancer patients

PROGRAM

Friday, 5th April, 2013

(Hall B)

P11. Breast cancer laterality among Egyptian patients and its correlation with treatments and survival

P12. Natural history of untreated hepatocellular carcinoma in Egypt: a retrospective cohort study

P13. Research in medical oncology: Past achievement and future priorities.P14. Evaluation of The Etiological Spectrum of Malignant Obstructive Jaundice At National

Cancer Institute, Cairo University

(15:30-17:30) Session XV: Advances in Radiodiagnosis

Chairpersons: Ahmed Sami - Ekram Hamed - Hossam Shalabi - Moharram El Badawy - Sherif Hegab

15:30-16:00 Interventional management of cholangio carcinomaWael Saad (Egypt)

16:00-16:30 Colorectal cancer: The radiologist' inputSherif Nour (USA)

16:30-17:00 Interventional management of benign and malignant biliary obstructionLouis Martin (USA)

17:00-17:30 Discussion

On behalf of everyone at NCI Conference, we would like to thank you all for your very generous sponsorship of our event, NCI Conference 2013 .It has been a great pleasure working with you.

This event would not have been a success without the generous support you have provided us throughout. We deeply appreciate the willingness with which you have and continue to sponsor our efforts to make our town a healthier, happier place to live in.

We sincerely hope that this association will be maintained and that you will continue to support us in our future endeavors.

Thank You

Platinum Sponsors